Search results
Results from the WOW.Com Content Network
Research programme: autism and obesity therapeutics - Berand Neuropharmacology – histone deacetylase inhibitors [61] Research programme: brain development disorder therapeutics - Seaside Therapeutics (STX-110) – metabotropic glutamate mGlu 5 receptor antagonists and muscarinic acetylcholine M 1 receptor antagonists [62]
Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different look: New rules require drugmakers to be clearer and more direct when ...
Pages in category "Autism screening and assessment tools" The following 16 pages are in this category, out of 16 total. This list may not reflect recent changes .
It authorizes the FDA to require a responsible person for a drug to conduct a post-approval study or clinical trial of the drug to assess a known serious risk or signals of a serious risk or to identify an unexpected serious risk, to require a postapproval study or clinical trial for an already approved drug only if the Secretary becomes aware ...
The Ritvo Autism & Asperger Diagnostic Scale (RAADS) is a psychological self-rating scale developed by Riva Ariella Ritvo (NPI UCLA and CSC Yale). An abridged and translated 14 question version was then developed at the Department of Clinical Neuroscience at the Karolinska Institute, to aid in the identification of patients who may have undiagnosed ASD.
Many autistic people have objected to Autism Speaks’ approach, given its lack of autistic leaders and its historic support for finding an autism “cure” (something the group says it no longer ...
A drug test (also often toxicology screen or tox screen) is a technical analysis of a biological specimen, for example urine, hair, blood, breath, sweat, or oral fluid/saliva—to determine the presence or absence of specified parent drugs or their metabolites.
Introduced in the Senate as the "Enduring Patient Access and Effective Drug Enforcement Act of 2015" by Orrin Hatch (R–UT) on February 12, 2015; Committee consideration by Senate Judiciary Committee; Passed the Senate on March 17, 2016 Passed the House on April 12, 2016 Signed into law by President Barack Obama on April 19, 2016